Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03279939 · ClinicalTrials.gov registry record
Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module
A clinical trial, sponsored by Heidelberg Engineering.
- Completed
- Registry status
- 88
- Enrollment target
NCT03279939 is a clinical trial that has completed, run by Heidelberg Engineering. The registered enrollment target is 88 participants.
The verdict
NCT03279939 has completed, sponsored by Heidelberg Engineering.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
Study Summary
Assessment of image quality and clinical relevance of OCT Angiography via comparison to FA/ICGA.
Interventions
- DEVICE OCT Angiography
- DEVICE Color Fundus Photography
- DEVICE Fluorescein Angiography
- DEVICE Indocyaine Green Angiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2017-08-23 |
| Est. Completion | 2018-01-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03279939
The ClinicalTrials.gov registry entry for NCT03279939 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heidelberg Engineering, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which OCT Angiography is the first listed.
NCT03279939 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03279939 about?
NCT03279939 is a clinical study titled "Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module". Assessment of image quality and clinical relevance of OCT Angiography via comparison to FA/ICGA.
What is the current status of trial NCT03279939?
This trial is currently completed. The enrollment target is 88 participants. The study started on 2017-08-23. Estimated completion is 2018-01-12.
What interventions are being tested in trial NCT03279939?
The interventions under investigation include: OCT Angiography (DEVICE), Color Fundus Photography (DEVICE), Fluorescein Angiography (DEVICE), Indocyaine Green Angiography (DEVICE).
Who is sponsoring clinical trial NCT03279939?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.